United States · Biotechnology startup
United States · Royalty Pharma
Industry leader in investing in marketed and late stage biopharmaceutical products
Funding reportedLast round: Post IPO debt
What company datasets say Royalty Pharma raised
Funding, as reported
Reported in all$1.5Bin dollars
Rounds3
Last roundPost IPO debt
Last round dateJun 2024
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Apogee TherapeuticsSan Francisco · founded 2022
Is this your company?
Add your raise, your deck and your story, and put Royalty Pharma in front of investors. Or tell us what we have wrong.